Evidence map›Paper›PMID 30690599›Full record

ReviewMedical mycology2019

Update on the Epidemiology of coccidioidomycosis in the United States.

Orion Z McCotter, Kaitlin Benedict, David M Engelthaler, Ken Komatsu, Kimberley D Lucas, Janet C Mohle-Boetani, Hanna Oltean, Duc Vugia, Tom M Chiller, Gail L Sondermeyer Cooksey and 4 more

Open access · hybridAbstract readReview
In one paragraph

Review in Medical mycology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 1 synthesis or guideline pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Neonatal management and outcomes in the setting of disseminated coccidioidomycosis in pregnancy.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The impact of bioinformatic choices onMicrobiology spectrum · 2025
    Article
  17. Article
  18. Pulmonary infection due toASM case reports · 2025
    Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Orion Z McCotterMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Kaitlin BenedictMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
David M EngelthalerTranslational Genomics Research Institute, Flagstaff, Arizona, USA.
Ken KomatsuArizona Department of Health Services, Phoenix, Arizona, USA.
Kimberley D LucasCalifornia Correctional Healthcare Services, Elk Grove, California, USA.
Janet C Mohle-BoetaniCalifornia Correctional Healthcare Services, Elk Grove, California, USA.
Hanna OlteanWashington State Department of Health, Shoreline, Washington, USA.
Duc VugiaCalifornia Department of Public Health, Richmond and Sacramento, California, USA.
Tom M ChillerMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Gail L Sondermeyer CookseyCalifornia Department of Public Health, Richmond and Sacramento, California, USA.
Alyssa NguyenCalifornia Department of Public Health, Richmond and Sacramento, California, USA.
Chandler C RoeTranslational Genomics Research Institute, Flagstaff, Arizona, USA.
Charlotte WheelerCalifornia Correctional Healthcare Services, Elk Grove, California, USA.
Rebecca SunenshineMaricopa County Department of Public Health, Phoenix, Arizona, USA.
California Department of Public Health · USCenters for Disease Control and Prevention · USArizona Department of Health Services · USMaricopa County Department of Public Health · USNorthern Arizona University · USTranslational Genomics Research Institute · USWashington State Department of Health · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

The incidence of reported coccidioidomycosis in the past two decades has increased greatly; monitoring its changing epidemiology is essential for understanding its burden on patients and the healthcare system and for identifying opportunities for prevention and education. We provide an update on recent coccidioidomycosis trends and public health efforts nationally and in Arizona, California, and Washington State. In Arizona, enhanced surveillance shows that coccidioidomycosis continues to be associated with substantial morbidity. California reported its highest yearly number of cases ever in 2016 and has implemented interventions to reduce coccidioidomycosis in the prison population by excluding certain inmates from residing in prisons in high-risk areas. Coccidioidomycosis is emerging in Washington State, where phylogenetic analyses confirm the existence of a unique Coccidioides clade. Additional studies of the molecular epidemiology of Coccidioides will improve understanding its expanding endemic range. Ongoing public health collaborations and future research priorities are focused on characterizing geographic risk, particularly in the context of environmental change; identifying further risk reduction strategies for high-risk groups; and improving reporting of cases to public health agencies.

Indexed as

ArizonaCaliforniaCoccidioidesCoccidioidomycosisHumansIncidencePhylogenyPrisonersPublic HealthRisk FactorsUnited StatesWashington

Identifiers

PMID30690599
PMCPMC6823633
OpenAlexW2913091535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.